Company Profile
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily provides the research and development, production, and marketing of therapeutic and biological drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs. Its portfolio also includes chemical drugs, and drugs for urinary, intestinal, infectious, autoimmune, nervous system, and diseases.
Founded in 2002, Its product portfolio includes Mouse Nerve Growth factor for injection, Compound Polyethylene Glycol Electrolyte Powder (IV), Troponium Chloride Capsules, Gliclazide extended-release tablets, Aspirin enteric-coated tablets, Compound polyethylene glycol (3350) electrolyte oral solution, Compound polyethylene glycol (3350) electrolyte vitamin C. Staidson (Beijing) BioPharmaceuticals is based in Beijing, China.